Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,927 | 5,135 | 3,419 | 3,564 | 3,149 |
| Operating Income | -4,927 | -5,135 | -3,419 | -3,564 | -3,149 |
| Interest Expense | 5 | 2 | 1 | 2 | 3 |
| Pre-tax Income | -4,932 | -5,137 | -3,420 | -3,566 | -3,152 |
| Net Income Continuous | -4,932 | -5,137 | -3,420 | -3,566 | -3,152 |
| Net Income | $-4,932 | $-5,137 | $-3,420 | $-3,566 | $-3,152 |
| EPS Basic Total Ops | -77,731.09 | -106,542.60 | -76,830.73 | -80,132.05 | -73,229.29 |
| EPS Basic Continuous Ops | -77,658.77 | -106,311.30 | -76,932.27 | -80,225.91 | -73,099.82 |
| EPS Diluted Total Ops | -77,731.09 | -106,542.60 | -76,830.73 | -80,132.05 | -73,229.29 |
| EPS Diluted Continuous Ops | -77,658.77 | -106,311.30 | -76,932.27 | -80,225.91 | -73,099.82 |
| EBITDA(a) | $-4,925 | $-5,132 | $-3,416 | $-3,561 | $-3,146 |